Andere Sprachen Pangenomic Health Inc.

Aktien

A4078Z

CA69842E3041

NARA

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 21:35:48 21.05.2024			% 5 Tage	% 1. Jan.
0.08 ^CAD	-11.11%		-33.33%	-60.00%

16.02.	Pangenomic Health Inc. kündigt Änderungen im Vorstand an	CI
2023	Pangenomic Health Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	13.04.
PanGenomic Health Announces Completion of Consolidation	21.03.
CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)	19.03.
PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE	18.03.
PanGenomic Health Announces Withdrawal from AQSE	20.02.
PanGenomic Health plans to withdraw shares from Aquis Stock Exchange	19.02.
PanGenomic Health Announces Changes to Board of Directors	16.02.
Pangenomic Health Inc. Announces Changes to Board of Directors	16.02.
PanGenomic Health agrees non-binding drawdown facility with Crescita	09.01.
PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility	09.01.
PanGenomic subsidiary reveals point-of-care vitamin D test	06.12.
PanGenomic Health Subsidiary Introducing Point-of-Care Vitamin D Test for Dental Implant Industry	06.12.
PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry	06.12.
Pangenomic Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way	22.11.
PanGenomic Health's MUJN sells first biomarker tests	17.11.
PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests	17.11.
PanGenomic Health Intends to Close Shares for Debt Settlement	01.11.
PanGenomic Health interim loss widens amid higher costs	30.08.23
PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023	30.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Pangenomic Health Inc.

Aktien

A4078Z

CA69842E3041

NARA

Andere Sprachen

Filter